Skip to main content

2024 Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Tolulope O. Adebusuyi, Ph.D

ORISE Fellow
US Food & Drug Administration

Poster(s):

165: Demographic Composition of New Molecular Entities Approved by the United States FDA Between 2017 & 2023 to Treat Type 2 Diabetes

Monday, September 9, 2024
5:00 PM – 7:00 PM ET